SEC Tracker
Get the app
Person · CIK 1588861

Sujal Shah

Director at Tvardi Therapeutics

Earlier: CymaBay Therapeutics

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$3.2M
Noticed on Form 144$3.2M
Bought on Form 4$630K
Companies2

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

CompanySecurityHeldShares or unitsAs of
Tvardi Therapeutics TVRDStock Option (right to buy)
exercise $2.78, expires Jun 8, 2036, into Common Stock
Directly6,000Jun 9, 2026 · Filing · EDGAR

Sold and noticed by quarter

Sujal Shah: dollars sold on Form 4 and noticed on Form 144 per quarter, Q1 2021 to Q4 2026$3.2M$0Q1 2021: $0 noticed on Form 144Q1 2021: $0 sold on Form 4Q2 2021: $0 noticed on Form 144Q2 2021: $0 sold on Form 4Q3 2021: $0 noticed on Form 144Q3 2021: $0 sold on Form 4Q4 2021: $0 noticed on Form 144Q4 2021: $0 sold on Form 4Q1 2022: $0 noticed on Form 144Q1 2022: $0 sold on Form 4Q2 2022: $0 noticed on Form 144Q2 2022: $0 sold on Form 4Q2 2022: $100K boughtQ3 2022: $0 noticed on Form 144Q3 2022: $0 sold on Form 4Q4 2022: $0 noticed on Form 144Q4 2022: $0 sold on Form 4Q1 2023: $0 noticed on Form 144Q1 2023: $0 sold on Form 4Q2 2023: $0 noticed on Form 144Q2 2023: $0 sold on Form 4Q3 2023: $0 noticed on Form 144Q3 2023: $0 sold on Form 4Q4 2023: $3.2M noticed on Form 144Q4 2023: $3.2M sold on Form 4Q1 2024: $0 noticed on Form 144Q1 2024: $0 sold on Form 4Q2 2024: $0 noticed on Form 144Q2 2024: $0 sold on Form 4Q3 2024: $0 noticed on Form 144Q3 2024: $0 sold on Form 4Q4 2024: $0 noticed on Form 144Q4 2024: $0 sold on Form 4Q1 2025: $0 noticed on Form 144Q1 2025: $0 sold on Form 4Q2 2025: $0 noticed on Form 144Q2 2025: $0 sold on Form 4Q3 2025: $0 noticed on Form 144Q3 2025: $0 sold on Form 4Q4 2025: $0 noticed on Form 144Q4 2025: $0 sold on Form 4Q1 2026: $0 noticed on Form 144Q1 2026: $0 sold on Form 4Q2 2026: $0 noticed on Form 144Q2 2026: $0 sold on Form 4Q3 2026: $0 noticed on Form 144Q3 2026: $0 sold on Form 4Q4 2026: $0 noticed on Form 144Q4 2026: $0 sold on Form 4Q1 2021Q2 2022Q3 2023Q4 2024Q1 2026

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table
QuarterSold (Form 4)Noticed (Form 144)Bought (Form 4)
Q4 2023$3.2M$3.2M—
Q2 2022——$100K
Q4 2019——$22K
Q3 2019——$28K
Q4 2018——$115K
Q3 2018——$55K
Q2 2018——$53K
Q3 2017——$73K
Q2 2016——$76K
Q2 2015——$34K
Q3 2014——$74K

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice dateNoticedPlanned saleOutcomeLinks
CymaBay Therapeutics · Morgan Stanley Smith Barney · 10b5-1 plan adopted Jun 28, 2023 · 3 notices
Dec 11, 202364,865 · ~$1.3MDec 11, 2023Sold as noticed Sold 64,865 in 2 sales, Dec 11 to Dec 11 · $1.3M Form 4Filing · EDGAR
Nov 13, 202364,863 · ~$1MNov 13, 2023Sold as noticed Sold 64,863 in 2 sales, Nov 13 to Nov 13 · $1M Form 4Filing · EDGAR
Oct 10, 202364,861 · ~$921KOct 9, 2023Sold as noticed Sold 64,861 at $14.20 on Oct 9 · $921K Form 4Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Tvardi Therapeutics TVRD Director · filings 2025 to 2026

DateTransactionSharesPriceValueHeld afterSource
Jun 9, 2026Grant or award from the company
Stock Option (right to buy)
+6,0006,000 directFiling · EDGAR
Apr 17, 2025Grant or award from the company
Stock Option (right to buy)
+12,00012,000 directFiling · EDGAR
Apr 15, 2025Grant or award from the company
Stock Option (right to buy)
+10,39410,394 directFiling · EDGAR
Apr 15, 2025Grant or award from the company
Stock Option (right to buy)
+8,0478,047 directFiling · EDGAR

CymaBay Therapeutics Chief Executive Officer · filings 2013 to 2024 · sold $3.2M · bought $630K · $3.2M noticed on Form 144

DateTransactionSharesPriceValueHeld afterSource
Mar 22, 2024Returned to the company−310,4200 directFiling · EDGAR
Mar 22, 2024Returned to the company−96,2500 directFiling · EDGAR
Mar 22, 2024Returned to the company
Employee Stock Option (right to buy)
−88,3510 directFiling · EDGAR
Mar 22, 2024Returned to the company
Employee Stock Option (right to buy)
−39,3750 directFiling · EDGAR
Mar 22, 2024Returned to the company
Employee Stock Option (right to buy)
−50,0000 directFiling · EDGAR
Mar 22, 2024Returned to the company
Employee Stock Option (right to buy)
−47,9160 directFiling · EDGAR
Mar 22, 2024Returned to the company
Employee Stock Option (right to buy)
−90,0000 directFiling · EDGAR
Mar 22, 2024Returned to the company
Employee Stock Option (right to buy)
−621,1010 directFiling · EDGAR
Mar 22, 2024Returned to the company
Employee Stock Option (right to buy)
−146,8750 directFiling · EDGAR
Mar 22, 2024Returned to the company
Employee Stock Option (right to buy)
−314,1200 directFiling · EDGAR
Mar 22, 2024Returned to the company
Employee Stock Option (right to buy)
−536,0320 directFiling · EDGAR
Mar 22, 2024Returned to the company
Employee Stock Option (right to buy)
−284,7120 directFiling · EDGAR
Mar 22, 2024Returned to the company
Employee Stock Option (right to buy)
−649,9990 directFiling · EDGAR
Mar 22, 2024Returned to the company
Employee Stock Option (right to buy)
−800,0000 directFiling · EDGAR
Mar 22, 2024Returned to the company
Employee Stock Option (right to buy)
−357,5000 directFiling · EDGAR
Mar 13, 2024Option or RSU exercised or converted+11,649$10.00$116K279,200 directFiling · EDGAR
Mar 13, 2024Option or RSU exercised or converted+14,625$1.06$16K293,825 directFiling · EDGAR
Mar 13, 2024Option or RSU exercised or converted+52,084$1.72$90K345,909 directFiling · EDGAR
Mar 13, 2024Option or RSU exercised or converted+18,899$9.21$174K364,808 directFiling · EDGAR
Mar 13, 2024Option or RSU exercised or converted+3,125$11.69$37K367,933 directFiling · EDGAR
Mar 13, 2024Option or RSU exercised or converted+14,372$8.43$121K382,305 directFiling · EDGAR
Mar 13, 2024Option or RSU exercised or converted+22,076$4.05$89K404,381 directFiling · EDGAR
Mar 13, 2024Option or RSU exercised or converted+2,288$5.78$13K406,669 directFiling · EDGAR
Mar 13, 2024Option or RSU exercised or converted+1$2.94$3406,670 directFiling · EDGAR
Mar 13, 2024Option or RSU exercised or converted
Employee Stock Option (right to buy)
−11,6490 directFiling · EDGAR
Mar 13, 2024Option or RSU exercised or converted
Employee Stock Option (right to buy)
−14,6250 directFiling · EDGAR
Mar 13, 2024Option or RSU exercised or converted
Employee Stock Option (right to buy)
−52,0840 directFiling · EDGAR
Mar 13, 2024Option or RSU exercised or converted
Employee Stock Option (right to buy)
−18,8990 directFiling · EDGAR
Mar 13, 2024Option or RSU exercised or converted
Employee Stock Option (right to buy)
−3,1250 directFiling · EDGAR
Mar 13, 2024Option or RSU exercised or converted
Employee Stock Option (right to buy)
−14,3720 directFiling · EDGAR
Mar 13, 2024Option or RSU exercised or converted
Employee Stock Option (right to buy)
−22,0760 directFiling · EDGAR
Mar 13, 2024Option or RSU exercised or converted
Employee Stock Option (right to buy)
−2,28812,845 directFiling · EDGAR
Mar 13, 2024Option or RSU exercised or converted
Employee Stock Option (right to buy)
−135,799 directFiling · EDGAR
Jan 24, 2024Grant or award from the company+96,250267,551 directFiling · EDGAR
Jan 24, 2024Grant or award from the company
Employee Stock Option (right to buy)
+357,500357,500 directFiling · EDGAR
Dec 11, 2023Option or RSU exercised or converted+63,975$5.00$320K235,276 directFiling · EDGAR
Dec 11, 2023Sale under a 10b5-1 plan−63,975$19.99$1.3M171,301 directFiling · EDGAR
Dec 11, 2023Option or RSU exercised or converted+890$5.00$4K172,191 directFiling · EDGAR
Dec 11, 2023Sale under a 10b5-1 plan−890$20.81$19K171,301 directFiling · EDGAR
Dec 11, 2023Option or RSU exercised or converted
Employee Stock Option (right to buy)
−31,0360 directFiling · EDGAR
Dec 11, 2023Option or RSU exercised or converted
Stock Appreciation Right
−12,9730 directFiling · EDGAR
Dec 11, 2023Option or RSU exercised or converted
Employee Stock Option (right to buy)
−20,8560 directFiling · EDGAR
Nov 13, 2023Option or RSU exercised or converted+44,008$5.00$220K215,309 directFiling · EDGAR
Nov 13, 2023Sale under a 10b5-1 plan−44,008$15.89$699K171,301 directFiling · EDGAR
Nov 13, 2023Option or RSU exercised or converted+20,855$5.00$104K192,156 directFiling · EDGAR
Nov 13, 2023Sale under a 10b5-1 plan−20,855$15.89$331K171,301 directFiling · EDGAR
Nov 13, 2023Option or RSU exercised or converted
Employee Stock Option (right to buy)
−31,03631,036 directFiling · EDGAR
Nov 13, 2023Option or RSU exercised or converted
Stock Appreciation Right
−12,97212,973 directFiling · EDGAR
Nov 13, 2023Option or RSU exercised or converted
Employee Stock Option (right to buy)
−20,85520,856 directFiling · EDGAR
Oct 9, 2023Option or RSU exercised or converted+64,861$5.00$324K236,162 directFiling · EDGAR
Oct 9, 2023Sale under a 10b5-1 plan−64,861$14.20$921K171,301 directFiling · EDGAR
Oct 9, 2023Option or RSU exercised or converted
Employee Stock Option (right to buy)
−31,03462,072 directFiling · EDGAR
Oct 9, 2023Option or RSU exercised or converted
Stock Appreciation Right
−12,97225,945 directFiling · EDGAR
Oct 9, 2023Option or RSU exercised or converted
Employee Stock Option (right to buy)
−20,85541,711 directFiling · EDGAR
Jan 25, 2023Grant or award from the company
Employee Stock Option (right to buy)
+800,000800,000 directFiling · EDGAR
Jun 6, 2022Open-market or private purchase+51,301$1.95$100K171,301 directFiling · EDGAR
Jan 25, 2022Grant or award from the company
Employee Stock Option (right to buy)
+650,000650,000 directFiling · EDGAR
Jan 26, 2021Grant or award from the company
Employee Stock Option (right to buy)
+287,000287,000 directFiling · EDGAR
May 15, 2020Grant or award from the company
Stock Option (Right to Buy)
+558,108558,108 directFiling · EDGAR
Oct 10, 2019Open-market or private purchase+5,000$4.30$22K120,000 directFiling · EDGAR

27 earlier transactions are in the filing list below.

All 40 Forms 3, 4, 5 and 144
FiledFormCompanyLinks
Jun 11, 2026Form 4Tvardi Therapeutics TVRDFiling · EDGAR
Apr 21, 2025Form 4Tvardi Therapeutics TVRDFiling · EDGAR
Apr 17, 2025Form 4Tvardi Therapeutics TVRDFiling · EDGAR
Apr 17, 2025Form 3Tvardi Therapeutics TVRDFiling · EDGAR
Mar 22, 2024Form 4CymaBay TherapeuticsFiling · EDGAR
Mar 15, 2024Form 4CymaBay TherapeuticsFiling · EDGAR
Jan 26, 2024Form 4CymaBay TherapeuticsFiling · EDGAR
Dec 11, 2023Form 144CymaBay TherapeuticsFiling · EDGAR
Dec 11, 2023Form 4CymaBay TherapeuticsFiling · EDGAR
Nov 14, 2023Form 4CymaBay TherapeuticsFiling · EDGAR
Nov 13, 2023Form 144CymaBay TherapeuticsFiling · EDGAR
Oct 10, 2023Form 144CymaBay TherapeuticsFiling · EDGAR
Oct 10, 2023Form 4CymaBay TherapeuticsFiling · EDGAR
Jan 27, 2023Form 4CymaBay TherapeuticsFiling · EDGAR
Jun 7, 2022Form 4CymaBay TherapeuticsFiling · EDGAR
Jan 27, 2022Form 4CymaBay TherapeuticsFiling · EDGAR
Jan 28, 2021Form 4CymaBay TherapeuticsFiling · EDGAR
May 19, 2020Form 4CymaBay TherapeuticsFiling · EDGAR
Oct 15, 2019Form 4CymaBay TherapeuticsFiling · EDGAR
Sep 24, 2019Form 4CymaBay TherapeuticsFiling · EDGAR
Jan 31, 2019Form 4CymaBay TherapeuticsFiling · EDGAR
Dec 21, 2018Form 4CymaBay TherapeuticsFiling · EDGAR
Oct 16, 2018Form 4CymaBay TherapeuticsFiling · EDGAR
Jul 30, 2018Form 4CymaBay TherapeuticsFiling · EDGAR
May 15, 2018Form 4CymaBay TherapeuticsFiling · EDGAR
Jan 26, 2018Form 4CymaBay TherapeuticsFiling · EDGAR
Oct 31, 2017Form 4CymaBay TherapeuticsFiling · EDGAR
Jul 24, 2017Form 4CymaBay TherapeuticsFiling · EDGAR
May 1, 2017Form 4CymaBay TherapeuticsFiling · EDGAR
Jan 23, 2017Form 4CymaBay TherapeuticsFiling · EDGAR
Jan 6, 2017Form 4CymaBay TherapeuticsFiling · EDGAR
Jan 4, 2017Form 4CymaBay TherapeuticsFiling · EDGAR
Apr 6, 2016Form 4CymaBay TherapeuticsFiling · EDGAR
Jan 28, 2016Form 4CymaBay TherapeuticsFiling · EDGAR
May 19, 2015Form 4CymaBay TherapeuticsFiling · EDGAR
Jan 8, 2015Form 4CymaBay TherapeuticsFiling · EDGAR
Sep 17, 2014Form 4CymaBay TherapeuticsFiling · EDGAR
Jan 8, 2014Form 4CymaBay TherapeuticsFiling · EDGAR
Dec 27, 2013Form 4CymaBay TherapeuticsFiling · EDGAR
Oct 11, 2013Form 3CymaBay TherapeuticsFiling · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched . The filing on SEC.gov is the record.